Affiliation:
1. DEPARTMENT OF CLINICAL PHARMACY, PHARMACOTHERAPY AND MEDICAL STANDARDIZATION, DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY, LVIV, UKRAINE
Abstract
The aim is to examine the state of a miscarriage of pregnancy problem and approaches to its solution based on current Ukrainian and international experience; to investigate a relevant set of terms and their interpretations that are tangible to the above-mentioned problem.
Materials and methods: modern information sources available for miscarriage and pregnancy loss. System analysis, bibliographic, bibliosemantic, comparative-and-analytical methods were used.
Conclusions: A relevant set of terms and their interpretations tangential to the identified problem (n=13) have been researched. It was found that the achievement of rational pharmacotherapy in patients with the threat of miscarriage is complicated mainly by the presence of 4 factors: extragenital pathology, burdened obstetric-gynecological anamnesis, lack of adequate drugs and possibilities of their prescription, especially in the 1st half of pregnancy. Disregarding these factors when prescribing medicines increases the risk of drug-related problems occurrence, prolongation of hospitalization and the adverse outcome of treatment (miscarriage). The results of the analysis of available information flow have shown the existence of terminological ambiguity related to the threat of miscarriage, in particular, there are often the following terms: spontaneous abortion, threatened abortion etc. instead of miscarriage, the threatened miscarriage which are recommended by international experts both in native Ukrainian and foreign researches. Unintended use of inadequate terms, in particular, «pregnancy failure» may form negative influence on women, cause the exaggeration of their condition, induce the feeling of despair, guilt, uncertainty associated with loss of the pregnancy.
Reference39 articles.
1. 1. Ectopic pregnancy and miscarriage: diagnosis and initial management. National Institute for Health and Care Excellence. Clinical Guidelines. April 2019; 126. Available from: https://www.nice.org.uk/guidance/ng126
2. 2. Pregnancy Loss (Before 20 Weeks) Research Information. US Department of Health and Human Services. Last Reviewed 2017. Available from: https://www.nichd.nih.gov/health/topics/pregnancyloss/researchinfo
3. 3. Vovk IB, Horovenko NH, Trokhimovich OV et al. Ranni reproduktyvni vtraty: etiolohiya, patohenetychni aspekty, diahnostychni ta likuval'ni zakhody [Early reproductive loss: etiology, pathogenetic aspects, diagnostic and therapeutic measures]. Health of Ukraine 2016; 1:37-40. (UA)
4. 4. Khomyak N. V., Mamchur V. I., Khomyak Ye .V. Kliniko-farmakologicheskiye osobennosti sovremennykh lekarstvennykh form mikronizirovannogo progesterona, primenyayushchikhsya vo vremya beremennosti [Clinical and pharmacological features of modern medicinal forms of micronized progesterone, used in pregnancy]. Medical aspects of women’s health 2015; 2(88):28-35. (Ru)
5. 5. Early pregnancy loss. Practice Bulletin No. 150. The American College of Obstetricians and Gynecologists 2015. Available from: https://www. acog.org/-/media/Practice-Bulletins/Committee-on-Practice-Bulletins- Gynecology/Public/pb150.pdf
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献